TCBP TC BioPharm Ltd: Net earnings per share for the last 12 months

Public company logo of TC BioPharm Ltd (TCBP)

TC Biopharm is developing cell therapy through alliances with oncology centers, excluding mergers. The YoY TTM EPS growth rate demonstrates the company's struggle with inflation within market cycles, where 0.00 shows the current value of the metric. Leadership in immunology enables the creation of OmnImmune drugs. Demand for tumor treatment remains stable, while the success of development depends solely on the availability of venture capital.

TCBP TC BioPharm (Holdings) Plc Earnings per share for the last twelve months (02/11/2024 - 02/20/2024)

Financial and market metric breakdowns for TC BioPharm (Holdings) PLC (TCBP)

- market value and analyst target forecast:
Stock Quotes TC BioPharm (Holdings) Plc|TCBP - Price Target Chart
- company stock capitalization data:
Market Valuation TC BioPharm|TCBP - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share TC BioPharm|TCBP - Company Book Value|Capitalization to Book Value Ratio tcbiopharm.com|TCBP - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital TC Biopharm|TCBP - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio TC Biopharm|TCBP - Company Aggregate Debts|Debt to Book Value TC BioPharm|TCBP - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings TC BioPharm|Quick Liquidity tcbiopharm.com
- earnings and multiples data:
TCBP - Net Profit|Company Profit Forecast TC Biopharm|TCBP - Price to Earnings Ratio|Projected Price to Earnings Ratio TC BioPharm Ltd|TCBP - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio TC BioPharm Ltd|TCBP - Operating profit EBITDA|Earnings per share for the trailing year TC BioPharm|TCBP - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth tcbiopharm.com|TCBP - Earnings per share growth in current year|Expected earnings per share trend next year TC Biopharm
- revenue and sales details:
TCBP - Company Revenue|Company Future Sales Volume TC BioPharm (Holdings) PLC|TCBP - Market Cap to Revenue|Price to Expected Revenue Ratio TC BioPharm Ltd
Fundamental company valuation:TC Biopharm
Core merchandise of TC BioPharm (Holdings) Plc

TC Biopharm is developing innovative cell therapy while facing logistical gaps and sanction barriers in its research. The trailing twelve-month earnings per share (EPS) trend digitizes the impact of these external constraints on bottom-line profitability. This metric measures net income growth rates, helping to balance potential returns against drawdown risk. Outperforming competitors confirms market leadership. An analysis of the trailing twelve-month EPS annual dynamics warns against overpaying for an overheated asset.

Direct competitors

argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) protagonist-inc.com|Earnings per share for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Net earnings per one share for the last twelve months|celldex.com - Net earnings per share (EPS TTM)|AUPH - Net earnings per share (EPS TTM)|BCRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pharvaris Pharma|Net earnings per share (EPS TTM) ABCL|TRML (tourmalinebio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PGEN (Precigen Inc)|PHAR - Net earnings per share for the last 12 months|NKTR - Earnings per share for the last twelve months|UPB - Net earnings per share (EPS TTM)|ZBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Immunome, Inc.|Earnings per share for the last twelve months Gossamer Bio|Net earnings per share (EPS TTM) KalVista Pharmaceuticals Inc|Net earnings per share for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SVRA (savarapharma.com)|Earnings per share for the trailing year RIGL|ANAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ATXS (Astria Therapeutics, Inc.)|ENGN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Earnings per share for the last twelve months aerovatetx.com|Net earnings per share (EPS TTM) aclaristx.com|Earnings per share for the last twelve months Kyverna Therapeutics (KYTX)|Net earnings per share for the last four quarters Tiziana Life Sciences Ltd|Net earnings per share (EPS TTM) CABA (Cabaletta Bio Inc)|VTYX: Earnings per share for the last 12 months|Theratechnologies, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Net earnings per share for the last 12 months|Agenus Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Climb Bio|Net earnings per share (EPS TTM) Zura Bio Ltd|Net earnings per share for the last 12 months ATYR (aTyr Pharma Inc)|Net earnings per share for the last four quarters Adagene Inc|Earnings per share for the last twelve months ImageneBio Inc IMA|Earnings per share for the last four quarters STTK (shattucklabs.com)|EQ: Net earnings per share for the last 12 months|CNTB: Earnings per share for the last twelve months|IMUX: Net earnings per share (EPS TTM)|Atara Biotherapeutics (ATRA) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months IFRX|Net earnings per share (EPS TTM) X4 Pharmaceuticals Inc.|Earnings per share for the last twelve months Adicet Bio Inc. (ACET)|Net earnings per share for the last 12 months Celularity CELU|Net earnings per share (EPS TTM) INMB (INmune Bio Corporation)|Net earnings per share for the last four quarters Barinthus Biotherapeutics (BRNS)|KZR - Earnings per share for the last twelve months|SABS - Net earnings per share (EPS TTM)|Akari Therapeutics, Plc (AKTX) - Earnings per share for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Net earnings per share (EPS TTM)|QTTB (Q32 Bio Inc) - Net earnings per share (EPS TTM)|geovax.com (GOVX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months EDSA (Edesa Biotech)|Net earnings per share for the last four quarters iBio Inc|Net earnings per share (EPS TTM) CARM (Carisma Therapeutics Inc)|Earnings per share for the trailing year XTLB|BOLT: Net earnings per share for the last 12 months|HCW Biologics (HCWB) - Net earnings per share for the last 12 months|Aptevo (APVO) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months AIM ImmunoTech|Net earnings per share for the last 12 months ADTX|GRI Bio Corporation (GRI) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Earnings per share for the last 12 months|Earnings per share for the last twelve months Revelation Biosciences Inc REVB|INDP - Net earnings per share for the last 12 months|SCNI: Net earnings per share for the last 12 months|CALI: Earnings per share for the last twelve months|AFMD: Net earnings per share (EPS TTM)|Allakos Inc - Earnings per share for the trailing year|Earnings per share for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)